Related Experiment Video
Updated: Aug 9, 2025
08:12
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
5.6K
Special Issue: Diagnostic and Predictive Tissue Markers in G.I. Cancers
Stefano Chillotti1,2, Francesco Vasuri1
1Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Cancers
|February 25, 2023
Summary
Systemic targeted therapies have transformed cancer treatment, reducing the need for traditional histopathological analyses. This shift highlights evolving diagnostic approaches in oncology.
Area of Science:
- Oncology
- Pathology
- Molecular Biology
Background:
- Recent decades have seen significant advancements in systemic targeted therapies for cancer.
- These innovations have fundamentally altered the practice and importance of histopathological analyses.
Discussion:
- The evolving landscape of cancer treatment necessitates a re-evaluation of the role of histopathology.
- Integration of molecular diagnostics alongside traditional histopathology is becoming increasingly crucial.
Key Insights:
- Histopathological analyses remain vital for initial diagnosis and tumor classification.
- Targeted therapies rely on specific molecular markers identified through advanced diagnostic techniques.
- The synergy between histopathology and molecular profiling optimizes patient stratification and treatment selection.
Outlook:
- Future cancer diagnostics will likely involve a multi-modal approach combining imaging, histopathology, and comprehensive genomic profiling.
- Continued research is needed to refine diagnostic workflows and biomarker discovery for personalized cancer care.
